Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-23-000320

Director bought 7,933,601 shares at $0.76 ($6,004,149)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nuechterlein Carole Director 2023-10-25 Purchase +7,933,601 $0.76 $6,004,149 11,025,941 I
Derivatives
Nuechterlein Carole Director 2023-10-25 Purchase · Warrant (Right to Buy) +3,966,800 $0.13 $495,850 3,966,800 I
Open-market purchases · 7,933,601 sh · avg $0.76 · $6,004,149
Loading xslF345X05/form4.xml…